Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype

Breast Cancer Research and Treatment

Volumn 57, Issue 3, 1999, Pages 237-243

  Garcia, Jose M ^a   Silva, Jose M ^a   Dominguez, Gemma ^a   Gonzalez, Rocio ^a   Navarro, Antonia ^a   Carretero, Luis ^b   Provencio, Mariano ^a   España, Pilar ^a   Bonilla, Felix ^a,c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c Clinica del Trabajo   (Spain)

Author keywords

Breast cancer; LOH; Polymorphic marker; Poor prognosis; PTEN

Indexed keywords

MICROSATELLITE DNA; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER GRADING; FEMALE; GENE LOSS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MICROSATELLITE REPEATS; NEOPLASM INVASIVENESS; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, PROGESTERONE;

EID: 0032804162     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006273516976     Document Type: Article

References (38)

1. 1. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH: Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2246, 1995
2. 2. Gray IC, Phillips SMA, Lee SJ. Neoptolemos JP, Weissenbach J, Spurr NK: Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55: 4800-4803, 1995
3. 3. Li J, Yen C, Liaw D, Podsypanlna K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosin phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997
4. 4. Steck PA, Perhouse MA, Jasser SA, Yunk WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15: 356-362, 1997
5. 5. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997-5000, 1997
6. 6. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R: PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene 16: 2879-2883, 1998
7. 7. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190, 1997
8. 8. Wang SI, Puc J, Li J, Bruce NJ, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastomas multiforme. Cancer Res 57: 4183-4186, 1997
9. 9. Dahia PLM, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C: Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57: 4710-4713, 1997
10. 10. Risinger JI, Hayes AK, Berchuck A, Barret JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736-4738, 1997
11. 11. Tashiro H, Blazes MS., Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH: Mutations in PTEN are frequent in endometrial carcinomas but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997
12. 12. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuci M, Sato S, Yin J, Wang S. Abraham JM, Souza RF, Smolionski KN, Meltzer SJ, Horil A: PTEN is frequently mutated in primary endometrial carcinomas. Nature Genet 17: 143-144, 1997
13. 13. Rhei E, Kang L, Bogomonniy F, Federichi MG, Borgen PI, Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657-3659, 1997
14. 14. Guldberg P, Straten PT, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663, 1997
15. 15. Cairns P, Evron E, Okami K, Halachmi N, Esteller M, Herman JG, Bose S, Wang SI, Parsons R, Sidransky D: Point mutations and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene 16: 3215-3218, 1998
16. 16. Liaw D, Marsh DJ. Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, and inherited breast and thyroid cancer syndrome. Nature Genet 16: 64-67, 1997
17. 17. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet 16: 333-334, 1997
18. 18. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Nagger A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WKA, Fujil G, Berson A, Bookstein R, Bolen JB, Tavtigian SV, Steck PA: MMAC1/PTEN mutations in primary tumor specimens and tumor cells lines. Cancer Res 57: 5221-5225, 1997
19. 19. Singh B, Ittmann MM, Krolewski JJ: sporadic breast cancer exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 21: 166-171, 1998
20. 20. Bose S, Wang SI, Terry MB, Hibshoosh H, Arsons R: Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene 17: 123-127, 1998
21. 21. Tsou HC, Teng DH, Ping XL, Brancoloini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV, Peacocke M: The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am 3 Hum Genet 61: 1036-1043, 1997
22. 22. Lynch ED, Ostermeyer EA, Lee MK Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, Macleod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Moller P, King MC: Inherited mutations in PTEN that are associated with breast cancer. Cowden disease, and juvenile polyposis. Am J Hum Genet 61: 1254-1260, 1997
23. 23. Tsou HC, Ping XL, Xie XX, Gruener AC, Zhang H, Nini R, Swisshelm K, Sybert V, Diamond TM, Sutphen R, Peacocke M: The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1. Hum Genet 102: 467-473, 1998
24. 24. Kellsell DP, Spurr NK, Barnes DM, Gusterson B, Bishop DT: Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347: 1554-1555, 1996
25. 25. Bcckmann MW, Picard F, An HX, van Roeyen CRC, Dominik SI, Mosny DS, Schnurch HG, Bender HG, Niederacher D: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220-1226, 1996
26. 26. Paulson TG, Wright FA, Parker BA, Russack V, Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996
27. 27. Oto M, Miyake S, Yuasa Y: Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Ann Biochem 213: 19-22, 1993
28. 28. Tamura M, Gu J, Matsumoto K, Aota S-I, Parsons R, Yamada KM: Inhibition of cell migration, spreading and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617, 1998
29. 1 growth arrest in glioma cells. Cancer Res 58: 5002-5008, 1998
30. 30. Li J, Simpson L, Takahashi M, Miliaresis Ch, Myers MP, Tonks N, Parsons R: The PTEN/MMAC1 tumor suppressor induces cell deaths that is rescued by the AKT/protein kinase B oncogene. Cancer Res 58: 5667-5672, 1998
31. 31. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Nature Genet 19: 348-355, 1998
32. 32. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58: 204-209, 1998
33. 33. Bièche I, Liderean R: Genetic alteration in breast cancer. Genes Chromosomes Cancer 14: 227-251, 1995
34. 34. Devillee P, Cornelisse C: Somatic genetic changes in human breast cancer. Biochim Biophys Acta 198: 113-130, 1994
35. 35. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jackemier J, Sobol H, Eisinger F, Birnbaum D: Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 57: 5469-5474, 1997
36. 36. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lidblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacious S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM. Deville P, Larsson C: Consortium study on 1280 breast carcinomas: allelic loss on chromosome target subregions associated with family history and clinical parameters. Cancer Res 58: 1004-1012, 1998
37. 37. Harris JR, Morrow M, Norton L: Malignant tumors of the breast. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer Principles and Practice of Oncology, 5th edition, Vol 2. pp 1557-1616 Lippincott-Noreu, Philadelphia, 1997
38. 38. van der Berg J, Johannsson O, Hakansson S, Olsson H, Borg A: Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74: 1615-1619, 1996